HSBC upgrades UnitedHealth to hold, sees risks priced in
https://seekingalpha.com/news/4087375-hsbc-upgrades-unitedhealth-to-hold-sees-risks-priced-in?source=feed_sector_healthcare
Apr 04, 2024 - HSBC has upgraded UnitedHealth Group (UNH) to hold from reduce, stating that it sees many of the current risks facing the company already baked into the price. Read more here.
0
Think Amazon Stock Has Peaked? Here's 1 Chart That Every Investor Needs to See.
https://www.fool.com/investing/2024/04/04/think-amazon-stock-has-peaked-heres-1-chart-that/?source=iedfolrf0000001
Apr 04, 2024 - This has been the best way to predict Amazon's stock price in the past.
0
Wall Street Analysts See GE HealthCare (GEHC) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2250422/wall-street-analysts-see-ge-healthcare-gehc-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2250422
Apr 04, 2024 - Based on the average brokerage recommendation (ABR), GE HealthCare (GEHC) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
Wall Street Analysts See PDD Holdings Inc. (PDD) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2250425/wall-street-analysts-see-pdd-holdings-inc-pdd-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2250425
Apr 04, 2024 - Based on the average brokerage recommendation (ABR), PDD Holdings Inc. (PDD) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
Jim Cramer sees Ford and Costco nearing buy levels. Here's the story behind each
https://www.cnbc.com/2024/04/03/jim-cramer-sees-ford-and-costco-nearing-buy-levels-heres-the-story-behind-each.html
Apr 03, 2024 - These two consumer-related stocks could be approaching new buying levels, according to Jim Cramer.
0
Wall Street Analysts See AvidXchange (AVDX) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2249701/wall-street-analysts-see-avidxchange-avdx-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2249701
Apr 03, 2024 - Based on the average brokerage recommendation (ABR), AvidXchange (AVDX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
Wall Street Analysts See General Motors (GM) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2249705/wall-street-analysts-see-general-motors-gm-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2249705
Apr 03, 2024 - Based on the average brokerage recommendation (ABR), General Motors (GM) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?
0
This Is the Biggest Mistake I See Cannabis Investors Making Over and Over Again
https://www.fool.com/investing/2024/04/02/this-is-the-biggest-mistake-i-see-cannabis-investo/?source=iedfolrf0000001
Apr 02, 2024 - Investors shouldn't assume the U.S. government will legalize marijuana anytime soon, and investing based on those hopes can be risky.
0
Billerud: I Now See A Difficult Medium-Term Forecast (Downgrade)
https://seekingalpha.com/article/4681603-billerud-stock-i-now-see-difficult-medium-term-forecast-downgrade?source=feed_all_articles
Apr 01, 2024 - Billerud faces challenges like weak sales, pricing pressure, and dependence on the market, affecting its dividend and US segment. Read more on BLRDY stock.
0
Wall Street Analysts See Nvidia (NVDA) as a Buy: Should You Invest?
https://www.zacks.com/stock/news/2248304/wall-street-analysts-see-nvidia-nvda-as-a-buy-should-you-invest?cid=CS-ZC-FT-fundamental_analysis|average_broker_rating-2248304
Apr 01, 2024 - According to the average brokerage recommendation (ABR), one should invest in Nvidia (NVDA). It is debatable whether this highly sought-after metric is effective because Wall Street analysts' recommendations tend to be overly optimistic. Would it be worth investing in the stock?
0